These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2010615)

  • 1. Gaucher's disease: lack of antibody response in 12 patients following repeated intravenous infusions of mannose terminal glucocerebrosidase.
    Murray GJ; Howard KD; Richards SM; Barton NW; Brady RO
    J Immunol Methods; 1991 Mar; 137(1):113-20. PubMed ID: 2010615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gaucher's disease: lack of antibody response to intravenous glucocerebrosidase.
    Britton DE; Leinikki PO; Barranger JA; Brady RO
    Life Sci; 1978 Dec; 23(25):2517-9. PubMed ID: 732537
    [No Abstract]   [Full Text] [Related]  

  • 3. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.
    Barton NW; Brady RO; Dambrosia JM; Di Bisceglie AM; Doppelt SH; Hill SC; Mankin HJ; Murray GJ; Parker RI; Argoff CE
    N Engl J Med; 1991 May; 324(21):1464-70. PubMed ID: 2023606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gaucher's disease: therapy by intravenous infusions of modified glucocerebrosidase.
    Beck M; Valadares ER; Lotz J
    Clin Investig; 1993 Jan; 71(1):78. PubMed ID: 8453266
    [No Abstract]   [Full Text] [Related]  

  • 5. Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system.
    Shaaltiel Y; Bartfeld D; Hashmueli S; Baum G; Brill-Almon E; Galili G; Dym O; Boldin-Adamsky SA; Silman I; Sussman JL; Futerman AH; Aviezer D
    Plant Biotechnol J; 2007 Sep; 5(5):579-90. PubMed ID: 17524049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the turnover of exogenous mannose-terminal glucocerebrosidase in rat liver lysosomes.
    Murray GJ; Oliver KL; Jin FS; Brady RO
    J Cell Biochem; 1995 Feb; 57(2):208-17. PubMed ID: 7759558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme replacement therapy in Gaucher's disease: a rapid, high-yield method for purification of glucocerebrosidase.
    Dale GL; Beutler E
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4672-4. PubMed ID: 1070017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a panel of highly sensitive, equivalent assays for detection of antibody responses to velaglucerase alfa or imiglucerase enzyme replacement therapy in patients with Gaucher disease.
    Séllos-Moura M; Barzegar S; Pan L; Shi P; Oommen S; Durant J; Ruiz JA
    J Immunol Methods; 2011 Oct; 373(1-2):45-53. PubMed ID: 21846471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of bone marrow failure in Gaucher's disease with low-dose modified glucocerebrosidase.
    Mistry PK; Davies S; Corfield A; Dixon AK; Cox TM
    Q J Med; 1992 Jul; 83(303):541-6. PubMed ID: 1484931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody response in patients with Gaucher disease after repeated infusion with macrophage-targeted glucocerebrosidase.
    Richards SM; Olson TA; McPherson JM
    Blood; 1993 Sep; 82(5):1402-9. PubMed ID: 8364193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocerebrosidase for treatment of Gaucher's disease: first German long-term results.
    Niederau C; Holderer A; Heintges T; Strohmeyer G
    J Hepatol; 1994 Oct; 21(4):610-7. PubMed ID: 7814809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alglucerase. A review of its therapeutic use in Gaucher's disease.
    Whittington R; Goa KL
    Drugs; 1992 Jul; 44(1):72-93. PubMed ID: 1379912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosurveillance of alglucerase enzyme therapy for Gaucher patients: induction of humoral tolerance in seroconverted patients after repeat administration.
    Rosenberg M; Kingma W; Fitzpatrick MA; Richards SM
    Blood; 1999 Mar; 93(6):2081-8. PubMed ID: 10068682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement In Symptoms Of Gaucher's Disease By Enzyme Replacement Therapy.
    Mazher W; Ali J; Abubakar S; Basar S; Murtaza G
    J Ayub Med Coll Abbottabad; 2018; 30(3):479-481. PubMed ID: 30465391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme replacement therapy for Gaucher's disease.
    Beutler E
    Baillieres Clin Haematol; 1997 Dec; 10(4):751-63. PubMed ID: 9497862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Enzymatic VLP-Nanoreactors with β-Glucocerebrosidase Activity as Potential Enzyme Replacement Therapy for Gaucher's Disease.
    Chauhan K; Olivares-Medina CN; Villagrana-Escareño MV; Juárez-Moreno K; Cadena-Nava RD; Rodríguez-Hernández AG; Vazquez-Duhalt R
    ChemMedChem; 2022 Oct; 17(19):e202200384. PubMed ID: 35918294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease.
    Schiffmann R; Heyes MP; Aerts JM; Dambrosia JM; Patterson MC; DeGraba T; Parker CC; Zirzow GC; Oliver K; Tedeschi G; Brady RO; Barton NW
    Ann Neurol; 1997 Oct; 42(4):613-21. PubMed ID: 9382473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and therapy of Gaucher disease].
    Ehlen C; Heintges T; Niederau C
    Med Klin (Munich); 1995 May; 90(5):284-90. PubMed ID: 7791695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of Gaucher's disease phenotypes with monoclonal antibody.
    Ginns EI; Tegelaers FP; Barneveld R; Galjaard H; Reuser AJ; Brady RO; Tager JM; Barranger JA
    Clin Chim Acta; 1983 Jul; 131(3):283-7. PubMed ID: 6883722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme replacement therapy in Gaucher's disease: large-scale purification of glucocerebrosidase suitable for human administration.
    Furbish FS; Blair HE; Shiloach J; Pentchev PG; Brady RO
    Proc Natl Acad Sci U S A; 1977 Aug; 74(8):3560-3. PubMed ID: 269414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.